Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Express Scripts
Moodys
QuintilesIMS
Argus Health
Teva
Boehringer Ingelheim
Mallinckrodt
Cerilliant
Deloitte

Generated: August 20, 2017

DrugPatentWatch Database Preview

CYSVIEW KIT Drug Profile

« Back to Dashboard

What is the patent landscape for Cysview Kit, and what generic Cysview Kit alternatives are available?

Cysview Kit is a drug marketed by Photocure Asa and is included in one NDA. There are two patents protecting this drug.

This drug has forty patent family members in twenty countries.

The generic ingredient in CYSVIEW KIT is hexaminolevulinate hydrochloride. Two suppliers are listed for this compound. Additional details are available on the hexaminolevulinate hydrochloride profile page.

Summary for Tradename: CYSVIEW KIT

Patents:2
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list27
Clinical Trials: see list438
Patent Applications: see list65
Drug Prices:see details
DailyMed Link:CYSVIEW KIT at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Photocure Asa
CYSVIEW KIT
hexaminolevulinate hydrochloride
FOR SOLUTION;INTRAVESICAL022555-001May 28, 2010RXYesYes► Subscribe► SubscribeY ► Subscribe
Photocure Asa
CYSVIEW KIT
hexaminolevulinate hydrochloride
FOR SOLUTION;INTRAVESICAL022555-001May 28, 2010RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CYSVIEW KIT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Photocure Asa
CYSVIEW KIT
hexaminolevulinate hydrochloride
FOR SOLUTION;INTRAVESICAL022555-001May 28, 2010► Subscribe► Subscribe
Photocure Asa
CYSVIEW KIT
hexaminolevulinate hydrochloride
FOR SOLUTION;INTRAVESICAL022555-001May 28, 2010► Subscribe► Subscribe
Photocure Asa
CYSVIEW KIT
hexaminolevulinate hydrochloride
FOR SOLUTION;INTRAVESICAL022555-001May 28, 2010► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: CYSVIEW KIT

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,335,684Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy► Subscribe
6,034,267 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy► Subscribe
7,850,008Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy► Subscribe
6,992,107Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy► Subscribe
8,410,172Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CYSVIEW KIT

Country Document Number Estimated Expiration
Norway2005024► Subscribe
European Patent Office0820432► Subscribe
Canada2215069► Subscribe
Japan4630395► Subscribe
Spain2188146► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: CYSVIEW KIT

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C019/2008Ireland► SubscribeSPC019/2008: 20090219, EXPIRES: 20190916
C/GB02/038United Kingdom► SubscribePRODUCT NAME: METHYL AMINOLEVULINATE, OPTIONALLY IN THE FORM OF A SALT, PREFERABLY METHYL AMINOLEVULINATE HYDROCHLORIDE; REGISTERED: SE 16338 20010615; UK PL18952/0002 20020408
0820432/02Switzerland► SubscribeFORMER REPRESENTATIVE: BOHEST AG, CH
0207Netherlands► Subscribe300207, 20160308, EXPIRES: 20190916
C/GB05/044United Kingdom► SubscribePRODUCT NAME: HEXYL AMINOLEVULINATE, OPTIONALLY IN THE FORM OF A SALT, PREFERABLY HEXYL AMINOLEVULINATE HYDROCHLORIDE; REGISTERED: SE 19227 20040917; UK PL 18952/0003 20050714
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Citi
Boehringer Ingelheim
Federal Trade Commission
Johnson and Johnson
Colorcon
Express Scripts
Argus Health
UBS
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot